OXFORD PKS HIGH FLEX TWIN PEG CEMENTED FEMUR MEDIUM
Report
- Report Number
- 3002806535-2022-00288
- Event Type
- Injury
- Date Received
- June 29, 2022
- Report Date
- July 21, 2022
- Manufacturer
- BIOMET UK LTD.
- Product Code
- NRA
- UDI-DI
- 00887868354854
- PMA / PMN Number
- P010014
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- 003
Narratives
(B)(4). CONCOMITANT MEDICAL PRODUCTS: OXF ANAT BRG LT MD SIZE 3 PMA ITEM#159547 LOT#6483393, OXF UNI CMNTLS TIB SZ C LM ITEM#166574 LOT#3922603, PALACOS R+G 2X40G ITEM #66017569 LOT #92804884. REPORT SOURCE: (B)(6). INVESTIGATION OF THIS INCIDENT IS CURRENTLY ONGOING. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MEDWATCH 3500A WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 3002806535 - 2022 ¿ 00286, 3002806535 - 2022 ¿ 00287.
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. NO PRODUCT WAS RETURNED OR PICTURES PROVIDED; VISUAL AND DIMENSIONAL EVALUATIONS COULD NOT BE PERFORMED TO CONFIRM REPORTED EVENT. REVIEW OF THE DEVICE HISTORY RECORD (DHR 166942 LO# J6466714) IDENTIFIED NO DEVIATIONS DURING MANUFACTURING RELATED TO THE REPORTED EVENT. DEVICES ARE USED FOR TREATMENT. MEDICAL RECORDS WERE NOT PROVIDED. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED.
IT WAS REPORTED THAT THE PATIENT UNDERWENT AN INITIAL LEFT KNEE ARTHROPLASTY AND APPROXIMATELY TWO (2) YEARS POST-IMPLANTATION IS STILL EXPERIENCING PAIN AND INSTABILITY. DUE DILIGENCE IS IN PROGRESS FOR THIS COMPLAINT; TO DATE NO ADDITIONAL INFORMATION HAS BEEN RECEIVED.
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1813314 | OXFORD PKS HIGH FLEX TWIN PEG CEMENTED FEMUR MEDIUM | KNEE PROSTHESIS | NRA | BIOMET UK LTD. | N/A | J6466714 | 00887868354854 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Other | SEE H10 NARRATIVE |